semaglutide dosage compared to tirzepatide vs Subcutaneously administered tirzepatide vs semaglutide

What insurance companies look for: Common prior authorization criteria include documented BMI meeting the FDA-approved threshold, documentation of weight-related comorbidities (for patients with BMI 27 to 29.9), evidence of previous weight loss attempts (diet, exercise, behavioral modification), a letter of medical necessity from your provider, and sometimes documentation that you have tried and failed other weight loss medications first (step therapy)

At that stage, your focus should shift to supporting your long-term success through sustainable lifestyle measures, including nutrition and exercise

Sometimes the oral formulation of tirzepatide produces different patterns of absorption and side effects that may be worth exploring if injectable tirzepatide has been problematic

Haase CL, Christensen M, Sonne DP, Vilsbll T, Knop FK

Daily Microdose Titration (Maximum Stability) The flattest concentration curve with P/T ratio of ~1.2